MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers

American Journal of Roentgenology

Volumn 204, Issue 3, 2015, Pages W348-W356

  Leong, Lester Chee Hao ^a   Gombos, Eva C ^a   Jagadeesan, Jayender ^a   Fook Chong, Stephanie Man Chung ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Breast neoplasms; Computer assisted detection; Kinetics; MRI; Volumetric analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR VOLUME; BREAST TUMOR; CHEMISTRY; IMAGE PROCESSING; KINETICS; PATHOLOGY; PROSPECTIVE STUDY;

BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84928428976     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11486     Document Type: Article

References (34)

1. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000; 217:841-848
2. Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001; 3:22-27
3. Barrett T, Kobayashi H, Brechbiel M, Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 2006; 60:353-366
4. Gaustad J V, Brurberg KG, Simonsen TG, Mollatt CS, Rofstad EK. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 2008; 10:354-362
5. Fernández-Guinea O, Andicoechea A, González LO, et al. Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinicopathological and biological factors in invasive breast cancer. BMC Cancer 2010; 10:8
6. Chen JH, Agrawal G, Feig B, et al. Triple-negative breast cancer: MRI features in 29 patients. Ann Oncol 2007; 18:2042-2043
7. Yaghan R, Stanton PD, Robertson KW, Going JJ, Murray GD, McArdle CS. Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol 1998; 24:424-426
8. Chang J, Clark GM, Allred DC, Mohsin S, Cham-ness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 2003; 97:545-553
9. Bauer KR, Brown M, Cress RD, Parise CA, Cag-giano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-nega-tive, and HER2/NEU-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 2007; 109:1721-1728
10. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13:4429-4434
11. Reis-Filho JS, Tutt AN. Triple negative tumors: a critical review. Histopathology 2008; 52:108-118
12. Lee SH, Cho N, Kim SJ, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Ra-diol 2008; 9:10-18
13. Chen JH, Baek HM, Nalcioglu O, Su MY. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging 2008; 27:825-833
14. Montemurro F, Martincich L, Sarotto I. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer. Eur Radiol 2007; 17:1490-1497
15. Schmitz AC, Smits ML, Veldhuis W, et al. Breast MR-imaging of ductal carcinoma in situ: a systematic review. Imaging Decisions MRI 2009; 13:112-121
16. Viehweg P, Lampe D, Buchmann J, Heywang-Köbrunner SH. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 2000; 11:129-137
17. Stomper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE. Angiogene-sis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997; 45:39-46
18. Tuncbilek N, Unlu E, Karakas HM, Cakir B, Ozy-ilmaz F. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance m a m m o g r a p h y. Breast J 2003; 9:403-408
19. Kuhl C. Dynamic breast magnetic resonance imaging. In: Morris EA, Liberman L, eds. Breast MRI. New York, NY: Springer, 2005:79-139
20. Koukourakis MI, Manolas C, Minopoulos G, Giatromanolaki A, Sivridis E. Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression, and early relapse in node-negative ductal carcinoma of the breast. Int J Surg Pathol 2003; 11: 29-34
21. Fuckar D, Dekanic A, Stifter S, et al. VEGF expression is associated with negative estrogen receptor status in patients with breast cancer. Int J Surg Pathol 2006; 14: 49-55
22. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-257
23. Raghunand N, Gatenby RA, Gillies RJ. Microen-vironmental and cellular consequences of altered blood fow in tumors. Br J Radiol 2003; 76(spec no. 1):S11-S22
24. Choi WW, Lewis MM, Lawson D, et al. Angio-genic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopath-ologic parameters and VEGF-family gene expression. Mod Pathol 2005; 18:143-152
25. Buadu LD, Murakami J, Murayama S. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histo-pathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649
26. Furuta A, Ishibashi T, Takahashi S, et al. Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis [in Japanese]. Nippon Igaku Ho-shasen Gakkai Zasshi 1999; 59:682-688
27. Koh TS, Thng CH, Hartono S, et al. Dynamic contrast-enhanced MRI of neuroendocrine hepatic metastases: a feasibility study using a dual-input two-compartment model. Magn Reson Med 2011; 65:250-260
28. Gokalp G, Topal U, Yildirim N, Tolunay S. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation. Eur J Radiol 2012; 81:203-208
29. Onishi M, Furukawa A, Takahashi M, Murata K. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study. Eur J Radiol 2008; 65:286-292
30. Weidner N, Semple J P, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8
31. Heldahl MG, Bathen TF, Rydland J, et al. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis. Acta Radiol 2010; 51: 604-612
32. Mehta S, Hughes N P, Buffa FM, et al. Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. J Natl Cancer Inst Monogr 2011; 2011:71-74
33. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007; 96:189-195
34. Jansen SA, Shimauchi A, Zak L, et al. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR 2009; 193:832-839